Cargando…

Plasma kallistatin in critically ill patients with severe sepsis and septic shock

Kallistatin, an endogenous serine proteinase inhibitor, is protective against sepsis in animal models. The aim of this study was to determine the plasma concentration of kallistatin in intensive care unit (ICU) patients with severe sepsis and septic shock and to determine their potential correlation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wei-Chieh, Chen, Chang-Wen, Chao, Lee, Chao, Julie, Lin, Yee-Shin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443576/ https://www.ncbi.nlm.nih.gov/pubmed/28542440 http://dx.doi.org/10.1371/journal.pone.0178387

Ejemplares similares

Plasma kallistatin levels in patients with severe community-acquired pneumonia
por: Lin, Wei-Chieh, et al.
Publicado: (2013)

Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis
por: Lin, Wei-Chieh, et al.
Publicado: (2015)

Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
por: Yao, Yuyu, et al.
Publicado: (2018)

Alkalosis in Critically Ill Patients with Severe Sepsis and Septic Shock
por: Kreü, Simon, et al.
Publicado: (2017)

Correction: Alkalosis in Critically Ill Patients with Severe Sepsis and Septic Shock
Publicado: (2017)

Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
por: Li, Pengfei, et al.
Publicado: (2015)

Chronically critically ill patients: different behavior in severe sepsis and septic shock?
por: Prevedello, DH, et al.
Publicado: (2015)

Dynamics of brain natriuretic peptide in critically ill patients with severe sepsis and septic shock
por: Omar, Amr S., et al.
Publicado: (2013)

Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway
por: Chao, Julie, et al.
Publicado: (2017)

Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children
por: Aygün, Fatih, et al.
Publicado: (2019)

Crystallization and crystallographic studies of kallistatin
por: Lin, Fang, et al.
Publicado: (2015)

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin
por: Shiau, Ai-Li, et al.
Publicado: (2010)

Acute Kidney Injury and Septic Shock—Defined by Updated Sepsis-3 Criteria in Critically Ill Patients
por: Wu, Vin-Cent, et al.
Publicado: (2019)

Severe Sepsis and Septic Shock
por: Opal, Steven M.
Publicado: (2008)

Prospective immune profiling in critically ill adults: before, during and after severe sepsis and septic shock
por: Layios, N
Publicado: (2015)

Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness
por: Lundberg, Oscar H. M., et al.
Publicado: (2020)

Hyperoxia in critically ill patients with sepsis and septic shock: a systematic review
por: Catalanotto, Francesca Romana, et al.
Publicado: (2023)

Effect of vitamin C in critically ill patients with sepsis and septic shock: A meta-analysis
por: Feng, Fang, et al.
Publicado: (2021)

Erratum: Prospective immune profiling in critically ill adults: before, during and after severe sepsis and septic shock
por: Layios, N., et al.
Publicado: (2015)

Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock
por: Chung, Kyung Soo, et al.
Publicado: (2017)

Novel Role of Kallistatin in Vascular Repair by Promoting Mobility, Viability, and Function of Endothelial Progenitor Cells
por: Gao, Lin, et al.
Publicado: (2014)

Past Experiences for Future Applications of Metabolomics in Critically Ill Patients with Sepsis and Septic Shocks
por: Trongtrakul, Konlawij, et al.
Publicado: (2021)

The Association Between Vitamin E Deficiency and Critically Ill Children With Sepsis and Septic Shock
por: Dang, Hongxing, et al.
Publicado: (2021)

The effect of meropenem versus piperacillin-tazobactam in critically ill patients with sepsis and septic shock()
por: Sun, Yang, et al.
Publicado: (2023)

Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation
por: Chao, Julie, et al.
Publicado: (2018)

Kallistatin reduces vascular senescence and aging by regulating microRNA‐34a‐SIRT1 pathway
por: Guo, Youming, et al.
Publicado: (2017)

Comparison of severity of illness scoring systems in the prediction of hospital mortality in severe sepsis and septic shock
por: Crowe, Colleen A, et al.
Publicado: (2010)

Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness
por: Granja, Cristina, et al.
Publicado: (2004)

Intensive care unit—acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock
por: Schefold, Joerg C., et al.
Publicado: (2010)

Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock
por: Ryu, Jeong-Am, et al.
Publicado: (2015)

Dosing errors of empirical antibiotics in critically ill patients with severe sepsis or septic shock: A prospective observational study
por: Al-Dorzi, Hasan M., et al.
Publicado: (2019)

The outcomes of severe sepsis and septic shock in the UK
por: Reuben, Adam D, et al.
Publicado: (2006)

Optimization of Preload in Severe Sepsis and Septic Shock
por: Shujaat, Adil, et al.
Publicado: (2012)

Severe sepsis and septic shock in Croatian ICUs
por: Gornik, I, et al.
Publicado: (2006)

Clinical implications of the plasma EphA2 receptor level in critically ill patients with septic shock
por: Lee, Su Hwan, et al.
Publicado: (2017)

Association between phosphate disturbances and mortality among critically ill patients with sepsis or septic shock
por: Al Harbi, Shmeylan A., et al.
Publicado: (2021)

Characterization of critically ill patients with septic shock and sepsis‐associated cardiomyopathy using cardiovascular MRI
por: Muehlberg, Fabian, et al.
Publicado: (2022)

Kallistatin - the score beats the marker
por: Draikiwicz, Steven, et al.
Publicado: (2013)

Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
por: Hartman, Stan J. F., et al.
Publicado: (2019)

Levosimendan does not reduce the mortality of critically ill adult patients with sepsis and septic shock: a meta-analysis
por: Feng, Fang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1nsrd88qld4kbv71uheo1mk7og